EMERALD · International PhD Programme for Medical Doctors
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2022-01-01 → 2027-06-30
- Финансиране от ЕС
- 2 278 080 €
- Участници
- 1
- Схема
- MSCA-COFUND
Линиите свързват координатора с партньорите.
Накратко на български
Програмата обучава лекари в молекулярните механизми на болестите и работата с модерни технологии. Това помага за по-бързото прилагане на лабораторните открития в реалната грижа за пациентите.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
International PhD Programme for Medical Doctors
Precision medicine is transforming healthcare, driving a demand for a deep understanding of the molecular basis of diseases alongside proficiency in cutting-edge technologies. However, the integration of this advanced knowledge into clinical practice faces significant hurdles. There are few physicians with comprehensive research training, and equally, research teams often lack specialists with direct clinical experience. This disconnect hinders the seamless translation of laboratory discoveries into effective patient care. As technology rapidly evolves, bridging this gap becomes increasingly crucial, highlighting the need for medical professionals who can navigate both the complexities of disease mechanisms and the latest advancements in medical technology. Historically, physician-scientists have been at the forefront of integrating scientific discoveries into clinical applications, playing a crucial role in the advancement of healthcare. Despite their importance, specialized research training programmes for medical doctors are remarkably rare, with most available programmes operating on a local scale, through a non-intensive research engagement, and often narrowly focused on highly translational research, thus limiting international collaborations and mobility, comprehensive development of research skills, and diminishes exposure to frontier research approaches that lay the groundwork for translational research. In response to these challenges, EMERALD emerges as the first European-wide PhD programme for Medical Doctors. EMERALD offers medical doctors an unparalleled opportunity to engage in intensive research experiences across 8 research centres of excellence in life sciences and biomedicine, which provide access to multi-disciplinary research teams and cutting-edge technologies, promoting both frontier and translational research approaches in 7 EU member states. Supported by 29 partner organizations from 10 EU member states, including academia, hospitals, industry, patient organizations, and NGOs, EMERALD embodies Europe's commitment to healthcare advancement. EMERALD goes beyond traditional PhD training by equipping physician-scientists with a broad spectrum of research and transferable skills through 3 Summer Schools and additional online courses, career development opportunities, mentoring, and access to advanced technologies and facilities. The programme champions equality, diversity, and inclusion, promoting international and intersectoral mobility and employing an open, merit-based, and transparent recruitment process for 24 medical doctors. The doctoral programme is designed to foster an ecosystem that not only supports but empowers the next generation of physician-scientists, ensuring they are well-prepared to lead in both academic and clinical settings. This collaborative network underscores the importance of integrating diverse perspectives and expertise in shaping the future of healthcare.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Addressing the increased need for innovative solutions in medicine and healthcare, as we are witnessing during the current worldwide pandemic, requires more than ever the rise of the unique professional profile of physician-scientists, combining cutting-edge research and technology with medicine. There are several MDPhD programmes in European countries and institutions, but there is none Europe-wide. The EMERALD International Doctoral Programme aims to nurture excellent physician-scientists to advance research, personalised medicine and health care in Europe. Following fair, merit-based, and inclusive recruitment, the programme will hire 24 medical doctors to carry out a PhD in cutting-edge research in seven European centres of excellence in life sciences and biomedicine. The EMERALD fellows will experience mobility across laboratories, sectors and countries, and they will benefit from international, stimulating and creative environments, advanced training, career development and mentoring programmes, and access to high-end technologies and facilities. Importantly, they will benefit from the advanced training on the latest technologies, digital skills, open science and innovation, and from the mentoring provided by the EMERALD programme, with the opportunity to build valuable international networks with different actors in academia, hospitals, industry, patients´ organisations and NGOs. EMERALD counts on the impressive support and collaboration of 37 partner organisations from 10 European countries. The trained physician-scientists will be equipped with skills and knowledge to tackle relevant clinical and research questions, bridging the gap between laboratory research and caring of patients, and ultimately pursuing new approaches to diagnose and treat human diseases.
Оригинален текст от CORDIS (на английски).
Участници
- FUNDACIO CENTRE DE REGULACIO GENOMICA · BarcelonaКоординаторИспания
Връзки
- Виж в CORDIS
- DOI: 10.3030/101034290
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5e7c13b1b&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5ef980349&appId=PPGMS
- https://emerald-mdphd.eu/
Данни: CORDIS, © Европейски съюз
